Dr. Ammar Alzoubi, MD
- Medicare services, 2024
- 771
- Medicare patients, 2024
- 325
- Part D claims, 2024
- 721
- Hospital affiliations
- 2
- Industry payments
- $484
- Practice address
- 200 Hygeia Dr, Newark, DE 19713
- Practice phone
- Call (302) 623-4285
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Helen F Graham Cancer Center & Research Institute
Newark, Delaware
Find Dr. Alzoubi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Ammar Alzoubi is a hematologist and oncologist in Newark, Delaware
Dr. Alzoubi practices at Helen F Graham Cancer Center & Research Institute in Newark, Delaware.
Dr. Alzoubi's NPI, 1386720340, was assigned on October 31, 2006. Dr. Alzoubi holds New York license 294498.
- NPI
- 1386720340NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1355383936
- NPI enumeration date
- October 31, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (302) 623-4285
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 64
- Medical school graduation
- 1988
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Ammar Alzoubi practices at Helen F Graham Cancer Center & Research Institute in Newark, Delaware
Dr. Alzoubi's primary practice is Helen F Graham Cancer Center & Research Institute, at 200 Hygeia Dr, Newark, DE 19713 in New Castle County. The practice phone is (302) 623-4285.
- Helen F Graham Cancer Center & Research Institute200 Hygeia Dr, Newark, DE 19713 · New Castle CountyPhone(302) 623-4285
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Ammar Alzoubi is affiliated with 4 sites of care and 1 medical group
Dr. Alzoubi's primary practice is Helen F Graham Cancer Center & Research Institute in Newark, Delaware. Dr. Alzoubi is also affiliated with Christiana Hospital. The medical group on file is ChristianaCare. Dmand AI also links Dr. Alzoubi to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Ammar Alzoubi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alzoubi practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Helen F Graham Cancer Center & Research Institute | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Ammar Alzoubi is one of 42 hematologists and oncologists in Delaware
Hematology and oncology is Dr. Alzoubi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Alzoubi's licenses on file in 4 states: New York, Delaware, Michigan and North Dakota.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
- Hematology (internal medicine), Delaware
- Internal medicine, Michigan
- North Dakota license
Hematologists and oncologists near Dr. Alzoubi
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Ammar Alzoubi billed Medicare for 771 services in 2024
CMS data shows 771 Medicare services from Dr. Alzoubi across 10 procedure codes in 2024, for 325 Medicare patients. Medicare paid $60,346 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Alzoubi's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8262024: 7529%
- Surgery
- 2023: 162024: 1919%
Dr. Alzoubi compared with the Delaware median for hematologists and oncologists, 2024
- Dr. Alzoubi
- Delaware median
- Medicare services
- 771vs 810Close to median
- Medicare patients
- 325vs 41121% below
- Part D claims
- 573vs 596Close to median
Medians across 40 hematologists and oncologists in Delaware with Dmand AI profiles that report each measure.
Dr. Alzoubi's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Alzoubi?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Alzoubi and other hematologists and oncologists in Delaware.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Ammar Alzoubi treated 325 Medicare patients in 2024, average age 75
CMS counts 325 Medicare patients who saw Dr. Alzoubi in 2024. The largest group is 75 to 84, with 140 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Alzoubi's median patient age at 69, with 54% women.
Dr. Alzoubi's Medicare patients by age, 2024
Dr. Alzoubi's Medicare patients by sex, 2024
- Women17754%
- Men14846%
Chronic conditions among Dr. Alzoubi's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis55%
- Chronic kidney disease42%
- Diabetes42%
- Ischemic heart disease37%
- Heart failure33%
- Mood disorders32%
Share of Medicare patients with each condition. A patient can have several.
Dr. Alzoubi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women54%
- Men45%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Ammar Alzoubi wrote 721 Medicare Part D claims in 2024
In 2024, Dr. Alzoubi wrote 721 Medicare Part D claims for 96 patients. 65% of them were for generic drugs. CMS names the drug for 573 of them, across 17 drugs with 11 or more claims each, at $4,263,258 in total drug cost. In 2023, CMS named 460 claims across 14 drugs.
Dr. Alzoubi's Part D claims by kind of drug, 2024
- Generic466 claims65%
- Brand-name255 claims35%
Dr. Alzoubi's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Alzoubi's Part D claims, 2024
- Antibiotics5%39 of 721 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4602024: 57325%
Drugs named by CMS: 17 in 2024, 14 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Ammar Alzoubi offers telehealth to Medicare patients
Dr. Alzoubi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alzoubi as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Ammar Alzoubi received $484 in industry payments from 2016 to 2025
CMS Open Payments shows 10 general payments to Dr. Alzoubi from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Alexion Pharmaceuticals, Inc. paid the most, $225.
General payments to Dr. Alzoubi by program year, 2016 to 2025
General payments to Dr. Alzoubi by kind, 2016 to 2025
- Food and beverage$43189%
- Education$5411%
Companies that paid Dr. Alzoubi the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Ammar Alzoubi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Ammar Alzoubi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Ammar Alzoubi's NPI number?
Dr. Ammar Alzoubi's NPI number is 1386720340. It was assigned on October 31, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Ammar Alzoubi?
Dr. Ammar Alzoubi is a hematologist and oncologist in Newark, Delaware. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Ammar Alzoubi practice?
Dr. Alzoubi practices at 200 Hygeia Dr, Newark, DE 19713. Dr. Alzoubi's primary practice is Helen F Graham Cancer Center & Research Institute in Newark, Delaware. Dmand AI also links Dr. Alzoubi to 1 hospital and 1 group practice or clinic.
What is Dr. Ammar Alzoubi's office phone number?
The practice phone on file for Dr. Alzoubi is (302) 623-4285.
What is Dr. Ammar Alzoubi's medical license number?
Dr. Alzoubi holds New York license 294498, one of the licenses on file in 4 states.
Which states has Dr. Ammar Alzoubi been licensed in?
Dmand AI has state licenses on file for Dr. Alzoubi in New York, Delaware, Michigan and North Dakota.
Which hospitals is Dr. Ammar Alzoubi affiliated with?
Dr. Alzoubi is affiliated with Christiana Hospital. Dmand AI links Dr. Alzoubi to 1 more hospital.
What medical group is Dr. Ammar Alzoubi part of?
Dr. Alzoubi is linked to ChristianaCare.
Does Dr. Ammar Alzoubi accept Medicare?
Yes. CMS data shows Dr. Alzoubi billed Medicare for 771 services in 2024, and Dr. Alzoubi accepts Medicare assignment.
Does Dr. Ammar Alzoubi offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Alzoubi as offering telehealth services.
Show 5 more questionsShow fewer questions
How many Medicare patients does Dr. Ammar Alzoubi see?
CMS counts 325 Medicare patients who saw Dr. Alzoubi in 2024, with an average age of 75.
What services does Dr. Ammar Alzoubi bill to Medicare?
In 2024, Dr. Alzoubi's most billed Medicare services were office visit, established patient (99213), hospital inpatient care (99233) and office visit, established patient (99214).
What drugs does Dr. Ammar Alzoubi prescribe most?
In 2024 Medicare Part D data, Dr. Alzoubi's most prescribed drugs by claims were Acyclovir, Lenalidomide and Hydroxyurea.
Has Dr. Ammar Alzoubi received payments from drug or device companies?
CMS Open Payments shows $484 in general payments to Dr. Alzoubi from 7 companies from 2016 to 2025. The largest total came from Alexion Pharmaceuticals, Inc.
How long has Dr. Ammar Alzoubi been practicing?
Dr. Alzoubi graduated from medical school in 1988, 38 years ago.
Selling to hematology and oncology practices?
See hematologists and oncologists in Delaware by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card